|
CN101829137A
|
|
Solid preparation with citicoline sodium and inosine as active ingredients and applications thereof
|
|
CN101829135A
|
|
Injection preparation with citicoline sodium and inosine as active ingredients, and application thereof
|
|
CN101987199A
|
|
Antipyretic and analgesic injection composition
|
|
CN101829136A
|
|
Oral liquid preparation with citicoline sodium and inosine as active ingredients and application thereof
|
|
CN102166213A
|
|
Composition using levalbuterol and ipratropium bromide as active ingredients
|
|
CN102174018A
|
|
New crystal form of neticonazole hydrochloride and preparation method thereof
|
|
CN101991853A
|
|
Statin magnesium-containing blood lipid lowering composition
|
|
CN101991577A
|
|
Novel mental medicinal composition
|
|
CN101991854A
|
|
Novel blood fat-lowering composition
|
|
CN101993417A
|
|
Stable novel crystal form of dimemorfan phosphate
|
|
CN101987106A
|
|
Injection composition containing Tenofovir and salt thereof
|
|
CN103951608A
|
|
Nilvadipine crystal forms and preparation method thereof
|
|
CN101987851A
|
|
Crystal forms of Acyclovir sodium dihydrate and preparation method thereof
|
|
CN104003957A
|
|
2-[3-cyano-4-isobutoxyphenyl]-4-methylthiazole-5-formic acid crystal form and preparation method thereof
|
|
CN103936689A
|
|
2-[3-cyano-4-isobutoxy phenyl]-4-methylthiazole-5-formic acid crystal forms and preparation method thereof
|
|
CN101953821A
|
|
Medicinal composition taking levalbuterol and ambroxol as main active ingredients
|
|
CN101863780A
|
|
Choline salt of hypolipidemic drug and preparation method and pharmaceutical use thereof
|
|
CN101856353A
|
|
Medicinal composition using tolperisone optical isomer as active ingredient
|
|
CN101836984A
|
|
Dextral-rabeprazole-magnesium-containing pharmaceutical preparation and preparation method thereof
|
|
CN101836948A
|
|
Nitro-brate-containing sustained-release solid preparation
|
